Issue 6, 2024

Correction: Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents

Abstract

Correction for ‘Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents’ by Avinash G. Vishakantegowda et al., RSC Med. Chem., 2024, 15, 704–719, https://doi.org/10.1039/D3MD00630A.

Associated articles

Article information

Article type
Correction
Submitted
21 May 2024
Accepted
21 May 2024
First published
12 Jun 2024
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2024,15, 2196-2197

Correction: Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents

A. G. Vishakantegowda, D. Hwang, P. Chakrasali, E. Jung, J. Lee, J. S. Shin and Y. Jung, RSC Med. Chem., 2024, 15, 2196 DOI: 10.1039/D4MD90022G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements